Cav-1 negative tumors show increased tumor progression, metastasis, and estrogen receptor-negative genotype compared to Cav-1 positive breast cancer (Sloan et al., 2009; Witkiewicz et al., 2009; Qian et al., 2011; Simpkins et al., 2012). The gene discussed is CAV1; the disease is breast carcinoma.